Wikipedia -WSS

Wikipedia

author：fashion 2025-08-28 08:47:05 - browse：81

The Food and Drug Administration on Friday approved a new, rapid-acting medicine made by Sage Therapeutics to treat postpartum depression, the first oral treatment for the condition. But the agency denied the company’s application for an indication for major depression, a much larger potential market.

The drug, which will be sold under the brand name Zurzuvae, is not meant to be taken chronically. Patients take it orally for 14 days. In two clinical trials, the drug was found to significantly improve depressive symptoms more than a placebo. The effect was maintained for four weeks after treatment.

“Maternal mental health has been sidelined for far too long, but today’s approval of Zurzuvae helps to change that. Women have been waiting for an oral medicine that can specifically and rapidly improve the symptoms of PPD and we are proud to be able to deliver that,” said Barry Greene, Sage’s CEO, in a press release.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： Congress might make insulin pumps more accessible to the blind

hotspot

focus

WSS

Why do women spend more than men on medical expenses?

Congress might make insulin pumps more accessible to the blind

Covid vaccines: Private market messier than government rollout

Medicaid, Medicare dual

Juul documents reveal insider tactics on political lobbying

Why do women spend more than men on medical expenses?

knowledge

Wikipedia

hotspot

Cancer drug shortages should be causing more outrage

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

In age of alternative facts, a scholarly course on calling out crap

STAT Boddities: What happens to the brain when we get scared?

Medicare proposal to cover medical devices draws a mixed reaction

FDA advisers vote against ALS treatment from BrainStorm

Activists slam private health insurers over coverage restrictions

Mindstrong's demise and the future of mental health care

23andMe had bad news about my health. I wish a person had delivered it

Congress might make insulin pumps more accessible to the blind

entertainment

Doctors on social media are being harassed and cyberbullied

Why Eli Lilly’s earnings didn’t quite live up to the hype

Bernie Sanders gets little from pharma CEOs on drug prices

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Sudafed saga points to U.S. issues with evaluating older drugs

Wikipedia

hotspot

focus

hotspot